Target intelligence / Profile preview

Axonal regeneration

Molecular classification
Other
01

Overview

Axonal regeneration is the biological process by which injured nerve fibers (axons) regrow to restore neural connectivity and function following damage. It involves complex molecular programs encompassing intrinsic neuronal growth pathways (e.g., upregulation of regeneration-associated genes, activation of transcription factors, reorganization of the cytoskeleton) and extrinsic factors such as the injury microenvironment, presence of inhibitory molecules, and clearance of myelin debris. Efficient axonal regeneration is robust in the peripheral nervous system (PNS), aided by macrophages and Schwann cells, but is limited in the central nervous system (CNS) due to inhibitory signaling, glial scarring, and a non-permissive milieu. Therapeutic approaches target these barriers by modulating molecular pathways, enhancing intrinsic growth potential, or changing the local environment to promote nerve repair and regain function.

Other names
Axon regenerationAxonal sproutingNerve regenerationNeurite outgrowth
02

Mechanism of action

Mechanisms of drugs/biologics that promote axonal regeneration include: Inhibition of axon growth inhibitors (e.g., Nogo receptor antagonism); Modulation of signaling pathways (e.g., JAK/STAT3, RhoA, cAMP, integrin signaling); Epigenetic modulation (enhancing histone acetylation to promote regeneration-associated gene expression); Stabilization of microtubules and cytoskeleton (e.g., paclitaxel).

03

Biological functions

Nerve repairNeural connectivity restorationRecovery after nervous system injuryCell growth and survival pathways
04

Disease associations

Neurodegenerative diseaseAmyotrophic lateral sclerosis (ALS)Spinal cord injuryPeripheral and central nervous system injuries
05

Safety considerations

Off-target effects related to manipulation of growth and survival pathwaysRisk of aberrant sprouting or miswiringPossible tumorigenic risk from excessive growth signal activationImmune responses to biologics or viral vectors
06

Interacting drugs

4-Methylhistamine dihydrochloride

3 more in the full profile.

07

Biomarkers

Regeneration-associated gene (RAG) expression (e.g., GAP-43, Coro1b, Rab13)Phosphorylation status of pathway proteins (e.g., STAT3, Dock6)Imaging and functional recovery assays in animal models (e.g., CTB-FITC labeling of axons, PLR response in optic nerve regeneration models)

Beyond the preview

Go deeper on Axonal regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axonal regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call